share_log

DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $49

DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $49

DA Davidson對Usana Health Sciences保持中立,將目標股價下調至49美元
Benzinga Real-time News ·  2022/10/27 16:51

DA Davidson analyst Linda Bolton Weiser maintains Usana Health Sciences (NYSE:USNA) with a Neutral and lowers the price target from $57 to $49.

Da Davidson分析師琳達·博爾頓·韋澤(Linda Bolton Weiser)維持Usana Health Science(紐約證券交易所代碼:USNA)的中性,並將目標價從57美元下調至49美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論